Leye He
Impact in
- Urology top 5%
- Urinary Bladder and Prostate Research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Urology 18
- Urinary Bladder and Prostate Research 14
- Urological Disorders and Treatments 7
Leye He
66 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 106
- Urology 119
- Cancer Research 253
- Oncology 240
- Molecular Biology 561
- Complementary and alternative medicine 51
Countries citing papers authored by Leye He
This map shows the geographic impact of Leye He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leye He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leye He more than expected).
Fields of papers citing papers by Leye He
This network shows the impact of papers produced by Leye He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leye He. The network helps show where Leye He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leye He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 6 | |
| 3 | [Up-regulated expression of miR-576 inhibits ALK4 expression, regulates JAK/STAT signaling pathway and promotes proliferation and migration of prostatic cancer cells]. | 2022 | 1 |
| 4 | 2022 | 1 | |
| 5 | 2020 | 32 | |
| 6 | 2018 | 12 | |
| 7 | 2017 | 3 | |
| 8 | 2017 | 8 | |
| 9 | 2017 | 32 | |
| 10 | 2017 | 37 | |
| 11 | 2016 | 69 | |
| 12 | 2016 | 7 | |
| 13 | 2015 | 7 | |
| 14 | 2015 | 44 | |
| 15 | 2015 | 43 | |
| 16 | 2015 | 4 | |
| 17 | 2015 | 14 | |
| 18 | 2014 | 4 | |
| 19 | 2014 | 28 | |
| 20 | 2012 | 25 |
About Leye He
Leye He is a scholar working on Urology, Cancer Research, Pulmonary and Respiratory Medicine, Rheumatology and Oncology, having authored 67 papers that have together received 1.1k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (14 papers), Prostate Cancer Diagnosis and Treatment (11 papers), Urological Disorders and Treatments (7 papers), Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (6 papers), Urinary and Genital Oncology Studies (6 papers), Sexual function and dysfunction studies (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Urology (119 citations), Cancer Research (253 citations), Oncology (240 citations), Molecular Biology (561 citations) and Complementary and alternative medicine (51 citations). Leye He has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhi Long, Jing Tan, Yuxin Tang, Yingbo Dai, Jianye Liu, Kun Yao, Xianzhen Jiang, Jin Tang, Zhiqiang Jiang and Yu Gan. Their work appears in journals such as Asian Journal of Andrology, Frontiers in Cellular and Infection Microbiology, Oncology Reports, Diagnostic Pathology and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.